newest glp 1 drug New GLP-1 Guidelines for Type 2 Diabetes in 2025 New Guidelines on GLP-1 Drugs
Description
Glycemic control appears similar between the two peptides
Weghuber D, Forslund A, Ahlstrom H, Alderborn A, Bergstrom K, Brunner S, et al
Proper storage is essential to maintain the medication's effectiveness
Yes, orforglipron is an oral GLP-1 receptor agonist currently under development, showing promising results in clinical trials for glycemic control and weight loss
